Overview |
bsm-51496M |
CD10 Monoclonal Antibody |
WB |
Human |
Specifications |
Unconjugated |
Mouse |
KLH conjugated synthetic peptide derived from human CD10 |
225-300/750 |
Monoclonal |
B12H1 |
IgM |
0.5ug/ul |
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
Target |
4311 |
P08473 |
Cell membrane |
MME; NEP; NEP_HUMAN; Atriopeptidase; CALLA; CD 10; CD10; Common acute lymphocytic leukemia antigen; DKFZp686O16152; EC 3.4.24.11; Enkephalinase; EPN; gp100; Membrane metallo endopeptidase; Membrane metalloendopeptidase; Membrane metalloendopeptidase neutral endopeptidase enkephalinase; Membrane metalloendopeptidase neutral endopeptidase enkephalinase CALLA CD10; Membrane metalloendopeptidase variant 1; Membrane metalloendopeptidase variant 2; MGC126681; MGC126707; Neprilysin; Neutral endopeptidase 24.11; Neutral endopeptidase; Neprilysin; Skin fibroblast elastase; SFE. |
Thermolysin-like specificity, but is almost confined on acting on polypeptides of up to 30 amino acids. Biologically important in the destruction of opioid peptides such as Met- and Leu-enkephalins by cleavage of a Gly-Phe bond. Able to cleave angiotensin-1, angiotensin-2 and angiotensin 1-9. Involved in the degradation of atrial natriuretic factor (ANF). Displays UV-inducible elastase activity toward skin preelastic and elastic fibers. |
Application Dilution |
WB |
=1:100-1000, |